nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate
|
Ebisawa, Kazutoshi |
|
|
101 |
11 |
p. 2551-2552 |
artikel |
2 |
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
|
Masetti, Riccardo |
|
|
101 |
11 |
p. 2497-2506 |
artikel |
3 |
A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia
|
Jin, Yuanyuan |
|
|
101 |
11 |
p. 2413-2419 |
artikel |
4 |
B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis
|
Satoh, Takashi |
|
|
101 |
11 |
p. 2433-2444 |
artikel |
5 |
B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma — a case report
|
Baermann, Ben-Niklas |
|
|
101 |
11 |
p. 2541-2542 |
artikel |
6 |
CALR loss-of-heterozygosity as a potential driver for extramedullary AML
|
Weller, Marie-Christine |
|
|
101 |
11 |
p. 2571-2573 |
artikel |
7 |
Cardiopulmonary testing in adult patients with β-thalassemia major in comparison to healthy subjects
|
Piatti, G. |
|
|
101 |
11 |
p. 2445-2452 |
artikel |
8 |
Catheter management across patients with hematologic malignancies and catheter-related blood stream infections: a systematic review
|
Heybati, Kiyan |
|
|
101 |
11 |
p. 2515-2524 |
artikel |
9 |
Circulating tumor DNA in Hodgkin lymphoma
|
Maco, Maria |
|
|
101 |
11 |
p. 2393-2403 |
artikel |
10 |
Clinical usefulness of a novel classification of T cell distribution patterns in the tumor microenvironment of follicular lymphoma to detect transformation
|
Miyashita, Hirotaka |
|
|
101 |
11 |
p. 2477-2483 |
artikel |
11 |
Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation
|
Ahmed, Maria Z. |
|
|
101 |
11 |
p. 2553-2554 |
artikel |
12 |
Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016
|
Toppila, Iiro |
|
|
101 |
11 |
p. 2485-2495 |
artikel |
13 |
Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation
|
Stempel, Jessica M. |
|
|
101 |
11 |
p. 2559-2561 |
artikel |
14 |
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation
|
Giammarco, S. |
|
|
101 |
11 |
p. 2565-2566 |
artikel |
15 |
Costs of matched-sibling, unrelated, and haploidentical hematopoietic cell transplantation and risk factors for greater financial burden — a Brazilian FACT-accredited single-center analysis
|
Arcuri, Leonardo Javier |
|
|
101 |
11 |
p. 2507-2513 |
artikel |
16 |
Daratumumab for the treatment of refractory idiopathic multicentric Castleman disease: a case report
|
Shi, Yujie |
|
|
101 |
11 |
p. 2529-2531 |
artikel |
17 |
Discontinuation of azacitidine in acute myeloid leukemia: a feasible option?
|
Boerekamps, Anne |
|
|
101 |
11 |
p. 2549-2550 |
artikel |
18 |
Efficacy and steroid-sparing effect of tacrolimus in patients with autoimmune cytopenia
|
Zhang, Ruoxi |
|
|
101 |
11 |
p. 2421-2431 |
artikel |
19 |
Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
|
Yin, Qingxia |
|
|
101 |
11 |
p. 2471-2476 |
artikel |
20 |
First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years’ experience
|
Hu, Jing |
|
|
101 |
11 |
p. 2405-2412 |
artikel |
21 |
Hematopoietic cell transplantation for MYSM1 deficiency: not so much an easy task
|
Hashem, Hasan |
|
|
101 |
11 |
p. 2543-2544 |
artikel |
22 |
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation
|
Harada, Naonori |
|
|
101 |
11 |
p. 2567-2569 |
artikel |
23 |
L-DEP regimen is effective as an initial therapy for adult EBV-HLH
|
Chen, Leilei |
|
|
101 |
11 |
p. 2461-2470 |
artikel |
24 |
Obituary Prof. Dr. med. Johann Rastetter (28th of March 1928–23rd of June 2022)—a leading German hematologist
|
Berdel, Wolfgang E. |
|
|
101 |
11 |
p. 2381-2382 |
artikel |
25 |
Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia
|
Santaliestra, Marta |
|
|
101 |
11 |
p. 2563-2564 |
artikel |
26 |
Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis
|
Gao, Fenghua |
|
|
101 |
11 |
p. 2383-2392 |
artikel |
27 |
Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide
|
Zhai, Yingying |
|
|
101 |
11 |
p. 2555-2557 |
artikel |
28 |
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria
|
Han, Bing |
|
|
101 |
11 |
p. 2537-2539 |
artikel |
29 |
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission
|
Sevindik, Omur Gokmen |
|
|
101 |
11 |
p. 2545-2547 |
artikel |
30 |
Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia
|
Atakhanov, Salim |
|
|
101 |
11 |
p. 2533-2536 |
artikel |
31 |
Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up
|
Chansavang, Albain |
|
|
101 |
11 |
p. 2453-2460 |
artikel |
32 |
Venetoclax combined with decitabine and HAAG regimen: a novel salvage strategy for relapsed/refractory T-cell acute lymphoblastic leukaemia
|
Zhu, Yuanxin |
|
|
101 |
11 |
p. 2525-2528 |
artikel |